This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: The University of North Carolina at Chapel Hill. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Scott Bultman: Innovator in Gastrointestinal Tissue Engineering
Introduction
Scott Bultman is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of methods for generating gastrointestinal epithelial tissue constructs. His innovative approach has the potential to advance research in gastrointestinal health and disease.
Latest Patents
Scott Bultman holds a patent for "Methods to generate gastrointestinal epithelial tissue constructs." This patent describes a method of creating a live cell construct by providing a non-cellular support, contacting live undifferentiated cells to the support, and propagating a gastrointestinal epithelial cell monolayer on the top surface. The live cells in the monolayer may include undifferentiated cells, such as stem or progenitor cells, and optionally differentiated cells like enterocytes and goblet cells. The constructs formed by these methods can be utilized in high-throughput screening and other applications.
Career Highlights
Scott Bultman is affiliated with the University of North Carolina at Chapel Hill, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to tissue engineering and its implications for medical research.
Collaborations
Scott Bultman has collaborated with esteemed colleagues, including Nancy L Allbritton and Scott Magness. These partnerships have contributed to the advancement of research in gastrointestinal tissue engineering.
Conclusion
Scott Bultman's contributions to the field of biomedical engineering, particularly through his patent on gastrointestinal epithelial tissue constructs, highlight his role as an innovator. His work at the University of North Carolina at Chapel Hill continues to pave the way for advancements in medical research and applications.